International Market Update and Health Canada approvals
Filed with ASX · · 4 pages · English
Earlier from Biome Australia
- Non-Deal Investor Presentation April 2024
- First Quarter of Positive Underlying Cash Flow
- Biome Releases First Half FY2024 Results
- Biome to launch into UK and Ireland health retail
- FY24 Revenue Guidance Upgrade to $12.5M
Later from Biome Australia
- Biome expects to exceed FY24 forecast
- Biome Achieves Record Sales Revenue in FY24
- Biome shares three-year revenue target
- Clinically Proven Cholesterol Reducing Probiotic Launched
- Financial Year 2024 Key Results
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia